Akso Health Group Sponsored ADR
AHG Healthcare Medical Distribution
Akso Health Group Sponsored ADR’s revenue for fiscal 2026 (year ended March 2026) was $13.8 million, down 6.40% from fiscal 2025.
Follow AHG
Akso Health Group Sponsored ADR (AHG) Altman Z-score
Akso Health Group Sponsored ADR's Altman Z-score for fiscal 2026 is 112.75, in the safe zone (above 2.99).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2026 | 112.75 | 102.74 |
| FY2025 | 10.01 | 0.52 |
| FY2024 | 9.49 | 13.94 |
| FY2023 | −4.45 | (3.86) |
| FY2022 | −0.58 | 2.17 |
| FY2021 | −2.75 | (1.91) |
| FY2020 | −0.84 | (4.43) |
| FY2019 | 3.59 | (13.07) |
| FY2018 | 16.66 | — |
How fiscal 2026’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | 0.95 | — | 1.14 | |
| Retained earnings / total assets | (1.15) | — | −1.61 | |
| EBIT / total assets | (0.11) | — | −0.36 | |
| Market value of equity / total liabilities | 189.16 | — | 113.50 | |
| Sales / total assets | 0.07 | — | 0.07 | |
| Altman Z-score | Safe zone | 112.75 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Safe zone | 23.59 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| AHG Akso Health Group Sponsored ADR | 113× |
| CAH Cardinal Health, Inc. compare | 5.1× |
| COR Cencora, Inc. compare | 4.8× |
| HKPD Cellyan Biotechnology Co., Ltd compare | 3.4× |
| YI 111, Inc. Sponsored ADR compare | 3.3× |
| HSIC Henry Schein, Inc. compare | 2.7× |
| ACH Accendra Health, Inc. compare | 0.4× |
| FOCL FocalTherics compare | −0.9× |
| COSM Cosmos Health Inc. compare | −2.5× |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets